Recherche
-
2PRESCRIBE AS INTERNATIONAL AND DIGITAL CASE-BASED PHARMACOTHERAPY EDUCATION AND RESEARCH PLATFORM
(European Journal of Clinical Pharmacology. vol. 78, n° SUPPL 1, pp. S50-S50, 2022-06)Article de revue -
De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring
(Blood. vol. 139, n° 16, pp. 2561-2565, 2022-04-21)Article de revue -
High-Dimensional Propensity Score-Adjusted Case-Crossover for Discovering Adverse Drug Reactions from Computerized Administrative Healthcare Databases
(Drug Safety, 2022-02-18)Article de revue -
Cardiovascular Adverse Events With Intravitreal Anti-Vascular Endothelial Growth Factor Drugs: A Systematic Review and Meta-analysis of Randomized Clinical Trials
(JAMA Ophthalmology, 2021-04-15)Article de revue -
A meta-epidemiological study found lack of transparency and poor reporting of disproportionality analyses for signal detection in pharmacovigilance databases
(Journal of Clinical Epidemiology, 2021-07-27)Article de revue -
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in France
(Drug Safety. vol. 46, n° 12, pp. 1381-1389, 2023-12-01)Article de revue -
DPP-4 Inhibitors in Combination with Lipid-Lowering Agents and Risk of Serious Muscular Injury: A Nested Case-Control Study in a Nationwide Cohort of Patients with Type 2 Diabetes Mellitus
(Drug Safety. vol. 43, n° 8, pp. 767-774, 2020)Article de revue -
High prevalence of spin was found in pharmacovigilance studies usingdisproportionality analyses todetectsafetysignals: a meta-epidemiologicalstudy: Spin in pharmacovigilance disproportionality analyses
(Journal of Clinical Epidemiology. vol. 138, pp. 73-79, 2021-06-26)Article de revue -
Will the future of pharmacovigilance be more automated?
(Expert Opinion on Drug Safety. vol. 22, n° 7, pp. 541-548, 2023-07-01)Article de revue -
Antipsychotics and risk of QT prolongation: a pharmacovigilance study
(Psychopharmacology. vol. 240, pp. 199-202, 2022-12-14)Article de revue